Cargando…
Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
Autores principales: | Azin, Marjan, Mahon, Andrew B., Isaacman, Steven, Seaman, Julia E., Allen, Isabel E., Szarek, Michael, Cornelius, Lynn A., Demehri, Shadmehr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927816/ https://www.ncbi.nlm.nih.gov/pubmed/35310879 http://dx.doi.org/10.1016/j.xjidi.2022.100104 |
Ejemplares similares
-
Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers
por: Azin, Marjan, et al.
Publicado: (2023) -
Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative Analysis
por: Singh, Rohan, et al.
Publicado: (2023) -
Non-adherence to topical treatments for actinic keratosis
por: Shergill, Bav, et al.
Publicado: (2013) -
Real-World Experience With Topical 5-Fluorouracil 4% (40 mg/g) Cream for the Treatment of Actinic Keratosis
por: Briatico, Giulia, et al.
Publicado: (2023) -
Patient‐reported skin reactions to 5% 5‐fluorouracil in treatment of actinic keratosis
por: Ahmady, S., et al.
Publicado: (2021)